Intellia Therapeutics (NTLA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LKQ (LKQ) delivered earnings and revenue surprises of 6.67% and 1.73%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Nice's (NICE) stock fell about 15% premarket on Thursday after first quarter and full year 2025 outlook missed estimates.

Comcast outperforms in Q4, but growth expectations are too high. Read why CMCSA stock’s valuation may not be as attractive as ...

B2Gold Corp. BTG reported adjusted earnings per share (EPS) of 1 cent for fourth-quarter 2024, missing the Zacks Consensus ...

Rivian is guiding for adjusted EBITDA of a loss of $1.9 billion to a loss of $1.7 billion for fiscal 2025. The company ...

JP Morgan analyst Rajat Gupta downgraded TrueCar, Inc. (NASDAQ:TRUE) from Overweight to Neutral. This week, the company reported fourth-quarter EPS loss of 7 cents per share, falling short of the ...

FTI Consulting, Inc. FCN reported unimpressive fourth-quarter 2024 results, wherein earnings and revenues missed the Zacks ...

Shares of Occidental Petroleum (OXY) are down in after-hours trading after the oil company reported earnings for its fourth ...

Uber is an attractive growth investment opportunity in the vehicles and parts sector and recently received backing by Bill ...

Alibaba (NYSE: BABA) reported strong fiscal Q3 results, with revenue of $38.38B (+8% Y/Y) and earnings per ADS of $2.93, ...

This Red-Hot Artificial Intelligence (AI) Stock Hits a Speed Bump. Here's Why You May Want to Buy It Hand Over Fist.